These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 6138042

  • 1. Inhibition of prostaglandin 15-hydroxydehydrogenase by sulphasalazine and a novel series of potent analogues.
    Berry CN, Hoult JR, Peers SH, Agback H.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2863-71. PubMed ID: 6138042
    [Abstract] [Full Text] [Related]

  • 2. Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28A.
    Berry CN, Hoult JR, Phillips JA, McCarthy TM, Agback H.
    J Pharm Pharmacol; 1985 Sep 01; 37(9):622-8. PubMed ID: 2867182
    [Abstract] [Full Text] [Related]

  • 3. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR, Moore PK.
    Br J Pharmacol; 1980 Apr 01; 68(4):719-30. PubMed ID: 6103724
    [Abstract] [Full Text] [Related]

  • 4. Effect of sulphasalazine on pulmonary inactivation of prostaglandin F2 alpha in the pig.
    Hellewell PG, Pearson JD.
    Br J Pharmacol; 1982 Jun 01; 76(2):319-26. PubMed ID: 6178459
    [Abstract] [Full Text] [Related]

  • 5. Sulphasalazine analogue Ph CH 44A: powerful and selective inhibitor of prostaglandin breakdown in vitro and in vivo.
    Moore PK, Ramcharan E, Hoult JR.
    Eur J Pharmacol; 1980 Feb 08; 61(3):287-92. PubMed ID: 6102524
    [Abstract] [Full Text] [Related]

  • 6. Organ selective conversion of prostaglandin D2 to 9 alpha, 11 beta-prostaglandin F2 and its subsequent metabolism in rat, rabbit and guinea pig.
    Hoult JR, Bacon KB, Osborne DJ, Robinson C.
    Biochem Pharmacol; 1988 Oct 01; 37(19):3591-9. PubMed ID: 3178873
    [Abstract] [Full Text] [Related]

  • 7. Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.
    Hoult JR, Moore PK.
    Br J Pharmacol; 1978 Sep 01; 64(1):6-8. PubMed ID: 29685
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological and biochemical actions of sulphasalazine.
    Hoult JR.
    Drugs; 1986 Sep 01; 32 Suppl 1():18-26. PubMed ID: 2877850
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs.
    Pacheco S, Hillier K, Smith CL.
    Braz J Med Biol Res; 1990 Sep 01; 23(12):1323-34. PubMed ID: 1983789
    [Abstract] [Full Text] [Related]

  • 10. Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?
    Berry CN, Prouteau M, Lloyd KG.
    Br J Pharmacol; 1988 Mar 01; 93(3):465-72. PubMed ID: 2897215
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ, Lo Casto M.
    Gut; 1983 Mar 01; 24(3):213-7. PubMed ID: 6131017
    [Abstract] [Full Text] [Related]

  • 12. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
    Hillier K, Mason PJ, Pacheco S, Smith CL.
    Br J Pharmacol; 1982 May 01; 76(1):157-61. PubMed ID: 6123357
    [Abstract] [Full Text] [Related]

  • 13. Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.
    Wong PY, Chao PH, McGiff JC.
    J Pharmacol Exp Ther; 1982 Dec 01; 223(3):757-60. PubMed ID: 6754908
    [Abstract] [Full Text] [Related]

  • 14. Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils.
    Williams JG, Hallett MB.
    Gut; 1989 Nov 01; 30(11):1581-7. PubMed ID: 2574700
    [Abstract] [Full Text] [Related]

  • 15. Selective actions of aspirin- and sulphasalazine-like drugs against prostaglandin synthesis and breakdown.
    Moore PK, Hoult JR.
    Biochem Pharmacol; 1982 Mar 15; 31(6):969-71. PubMed ID: 6123327
    [Abstract] [Full Text] [Related]

  • 16. Structure-activity relationships in the oxidation of benzylamine analogues by bovine liver mitochondrial monoamine oxidase B.
    Walker MC, Edmondson DE.
    Biochemistry; 1994 Jun 14; 33(23):7088-98. PubMed ID: 8003474
    [Abstract] [Full Text] [Related]

  • 17. Actions of flavonoids and the novel anti-inflammatory flavone, hypolaetin-8-glucoside, on prostaglandin biosynthesis and inactivation.
    Alcaraz MJ, Hoult JR.
    Biochem Pharmacol; 1985 Jul 15; 34(14):2477-82. PubMed ID: 3839399
    [Abstract] [Full Text] [Related]

  • 18. Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.
    Szumlanski CL, Weinshilboum RM.
    Br J Clin Pharmacol; 1995 Apr 15; 39(4):456-9. PubMed ID: 7640156
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM, Bartholomew TC, Jewell DP.
    Gut; 1981 Aug 15; 22(8):642-7. PubMed ID: 6116649
    [Abstract] [Full Text] [Related]

  • 20. The effect of sulphasalazine on the in vitro activation of human peripheral blood mononuclear cells by phytohemagglutinin P.
    Pacheco S, Jones DB, Hillier K.
    Braz J Med Biol Res; 1989 Aug 15; 22(4):513-6. PubMed ID: 2574059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.